... prone to fractures. Despite excessive erythropoietic activity, affected persons suffer from anemia, which is exacerbated by progressive splenomegaly and an increase in plasma volume as a result of ...
... cell-based system for studying sickle cell anemia by reprogramming somatic cells to an embryonic stem ... -based system for studying sickle cell anemia by reprogramming somatic cells to an embryonic stem ...
... and health consequences of multiple infections for parasite-associated morbidity such as anemia are not clearly understood.
Previous work by these scientists suggested that low-intensity ...
... of a gene in one of the world's most common blood disorders, beta-thalassemia, commonly known as Cooley's anemia. Along with sickle-cell anemia, Cooley's anemia is the most commonly inherited disease ...
... Administration on Wednesday ordered changes in the prescribing information for two widely used anemia drugs, saying the risks of the medications outweigh the benefits for certain cancer patients....
... the past 15 years, erythropoiesis-stimulating agents have been used in the management of cancer-related anemia, but researcher Eirini Katodritou stresses the possible harmful effects ESAs may have on ...
... patients would be better off without it," state the authors.
However, they suggest that anemia of chronic disease has the characteristics of an adaptive physiologic response, and their review of ...
The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product’s safety.
... darbepoetin alfa plus or minus iron.
"In a large subset of patients with cancer-related anemia, an important factor that limits their response to treatment is the presence of an iron deficiency," Dr. ...
LONDON, Sept. 18 (UPI) -- British and U.S. scientists say nearly 7 million pregnant women in sub-Saharan Africa are infected with hookworms and, therefore, are at risk of anemia.
Federal health officials said that they were reviewing a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug in a German study of stroke patients.
... of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that preventing anemia in kidney disease patients should be an integral part of their care. Erythropoiesis- ...
... which uses keratinocytes, begins to help explain some of these changes.
Together with physicians in the Fanconi Anemia Comprehensive Care Center at Cincinnati Children's, Dr. Wells' team collected ...
... CKD patients. Because blood is removed during dialysis, CKD patients undergoing this treatment often have anemia, or low red blood cell counts. These patients also are often iron deficient and must ...
... . The most common treatments include blood transfusions and corticosteroids. The disease is characterized by extreme anemia—with a propensity to develop into leukemia—and often has no cure.
Using a ...
